Trade AVBP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ArriVent BioPharma, Inc. (AVBP) is trading at US$29.00, up 1.05% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$1.44B. Over the past 52 weeks, AVBP has traded between US$17.00 and US$35.83. On Syfe you can trade AVBP with $0 commission and add it to your watchlist.
| Previous close | US$28.70 |
|---|---|
| Market cap | US$1.44B |
| 52-week range | US$17.00 – US$35.83 |
| Volume | 1.13M |
| Exchange | US |
Add to Watchlist
Set Price Alert
ArriVent BioPharma, Inc.
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Year: 2024
B. Riley Adjusts ArriVent BioPharma Price Target to $45 From $37, Maintains Buy Rating
Mar 23, 12:15 PM · MT Newswires
ArriVent BioPharma, Inc. (AVBP) stock is trading at US$29.00, +1.05% from the previous close of US$28.70.
The market cap for ArriVent BioPharma, Inc. (AVBP) stock is approximately US$1.44B.
The 52-week high for ArriVent BioPharma, Inc. (AVBP) stock is US$35.83.
The 52-week low for ArriVent BioPharma, Inc. (AVBP) stock is US$17.00.
ArriVent BioPharma, Inc. (AVBP) does not currently pay a dividend.
Stay on top of AVBP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
